https://www.selleckchem.com/pr....oducts/adavivint.htm
Anemia has and will continue to be a central theme in medicine particularly as clinicians are treating a burgeoning population of complex multi-organ system processes. As a result of multiple randomized controlled trials (RCTs), meta-analyses, and societal recommendations overly restrictive paradigms and under-administration of erythropoiesis stimulating agents (ESAs) have likely been followed by clinicians among all specialties. A review of anemia in the context of chronic kidney disease, hematologic malignancies, and cancer is prese
Like
Comment
Share
